BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.53
+0.30 (5.74%)
At close: Oct 8, 2025, 4:00 PM EDT
5.57
+0.04 (0.72%)
After-hours: Oct 8, 2025, 6:45 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $9.94 million as of October 8, 2025. Its market cap has increased by 36.94% in one year.
Market Cap
9.94M
Enterprise Value
6.52M
1-Year Change
36.94%
Ranking
Category
Stock Price
$5.53
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $9.94M, a decrease of -76.41%. That is a compound annual growth rate of -24.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 9.40M | 86.97% |
Dec 31, 2024 | 5.03M | -46.33% |
Dec 29, 2023 | 9.36M | -94.33% |
Dec 30, 2022 | 165.03M | -54.75% |
Dec 31, 2021 | 364.69M | 54.35% |
Dec 31, 2020 | 236.28M | 460.98% |
Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Linde | 219.71B |
BHP Group | 140.78B |
Rio Tinto Group | 114.65B |
Southern Copper | 105.57B |
Newmont | 96.90B |
Agnico Eagle Mines | 85.60B |
The Sherwin-Williams Company | 83.77B |
Ecolab | 79.34B |